Showing results (541-550 of 25,160) with videos related to

Sort By:
Pageof 2,516
Oncotarget|January 27, 2018
LKB1 loss cooperating with BRAF V600E promotes melanoma cell invasion and migration by up-regulation MMP-2 via PI3K/Akt/mTOR pathwayWeiming Zhang, Li Yin, Guoxin Song, et al.
Oncotarget|January 27, 2018
Knock-in human GDF5 proregion L373R mutation as a mouse model for proximal symphalangismXinxin Zhang, Xuesha Xing, Xing Liu, et al.
Oncotarget|January 27, 2018
Highly preserved consensus gene modules in human papilloma virus 16 positive cervical cancer and head and neck cancersXianglan Zhang, In-Ho Cha, Ki-Yeol Kim
Oncotarget|January 27, 2018
Prognostic values of long non-coding RNA MIR22HG for patients with hepatocellular carcinoma after hepatectomyYuan Dong, Weiwei Yan, Shi-Long Zhang, et al.
Oncotarget|January 27, 2018
Novel proteasome inhibitor delanzomib sensitizes cervical cancer cells to doxorubicin-induced apoptosis via stabilizing tumor suppressor proteins in the p53 pathwayKevin Y Guo, Lili Han, Xinyu Li, et al.
Oncotarget|January 27, 2018
HDAC inhibition potentiates immunotherapy in triple negative breast cancerManuela Terranova-Barberio, Scott Thomas, Niwa Ali, et al.
Oncotarget|January 27, 2018
Insulin and novel thioglycosides exert suppressive effect on human breast and colon carcinoma cellsSiddarth Agrawal, Marta Wozniak, Mateusz Luc, et al.
Oncotarget|January 27, 2018
Biomarkers identification by a combined clinical and metabonomics analysis in Henoch-Schonlein purpura nephritis childrenLin Sun, Biao Xie, Qiuju Zhang, et al.
Oncotarget|January 27, 2018
Relationships between lymphocyte counts and treatment-related toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitorsAdam Diehl, Mark Yarchoan, Alex Hopkins, et al.
Oncotarget|January 27, 2018
MicroRNA-424/E2F6 feedback loop modulates cell invasion, migration and EMT in endometrial carcinomaZheng Lu, Zhou Nian, Zhang Jingjing, et al.
Pageof 2,516